.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
QuintilesIMS
Federal Trade Commission
US Department of Justice
Medtronic
Novartis
Julphar
Dow
Cerilliant
Boehringer Ingelheim

Generated: July 23, 2017

DrugPatentWatch Database Preview

TOLBUTAMIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Tolbutamide, and what generic Tolbutamide alternatives are available?

Tolbutamide is a drug marketed by Watson Labs, Barr, Dava Pharms Inc, Alra, Ascot, Mylan Pharms Inc, Parke Davis, Purepac Pharm, Sandoz, Vangard, Ivax Pharms, and Superpharm. and is included in sixteen NDAs.

The generic ingredient in TOLBUTAMIDE is tolbutamide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tolbutamide profile page.

Summary for Tradename: TOLBUTAMIDE

Patents:0
Applicants:12
NDAs:16
Suppliers / Packagers: see list1
Bulk Api Vendors: see list65
Clinical Trials: see list22
Patent Applications: see list6,205
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TOLBUTAMIDE at DailyMed

Pharmacology for Tradename: TOLBUTAMIDE

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
TOLBUTAMIDE
tolbutamide
TABLET;ORAL086109-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Alra
TOLBUTAMIDE
tolbutamide
TABLET;ORAL086141-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
TOLBUTAMIDE
tolbutamide
TABLET;ORAL087318-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sandoz
TOLBUTAMIDE
tolbutamide
TABLET;ORAL086574-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ascot
TOLBUTAMIDE
tolbutamide
TABLET;ORAL087541-001Mar 1, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Farmers Insurance
US Department of Justice
Express Scripts
Colorcon
Daiichi Sankyo
Citi
Moodys
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot